Is Teva Pharmaceutical stock a buy?

Yes, Teva Pharmaceutical pays dividends. Last time was Tuesday 12th of December 2017 where the investors holding the stock on Tuesday 28th of November 2017 were paid $0.085 per share. Over the last 30 times between 2010 and 2017, Teva Pharmaceutical has paid $18.853 with an average of $0.63 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Teva Pharmaceutical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $10.40, you would have made a profit of $5.38 per share or 51.73%

No, the average daily trading liquidity for Teva Pharmaceutical is $43 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Teva Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Teva Pharmaceutical to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.